Ultragenyx Pharmaceutical | Resultat Før Skatt



Pre Tax Profit Endring Dato
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Insmed USD -234282000 14.77M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
Kyowa Hakko Kirin JPY 25.05B 3.37B 2024-09
MacroGenics USD -14477000 70.79M 2024-12
Moderna USD -1184000000 1.2B 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Ultragenyx Pharmaceutical Resultat Før Skatt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.